Aduro purchasing all assets related to BioSante's GVAX cancer vaccines, including IP and cell lines

BioSante Pharmaceuticals Inc.

U.S. / Small-Cap Biopharma (<$1 billion)

Seller

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Aduro Biotech Inc.

U.S. / Private Biopharma

Buyer

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced